mic19 Antibody

What is MIC19 and what cellular functions does it perform?

MIC19 (also known as CHCHD3) is a component of the MICOS complex, a large protein assembly in the mitochondrial inner membrane that is crucial for maintaining crista junctions, inner membrane architecture, and forming contact sites with the outer membrane . Beyond its structural role in mitochondria, MIC19 has been shown to function as a transcription factor that binds to the BAG1 promoter and represses BAG1 transcription . The protein's molecular weight is approximately 26 kDa, and it contains coiled-coil-helix-coiled-coil-helix domains that are important for its function . In recent studies, MIC19 has demonstrated neuroprotective properties by mitigating cell apoptosis, preventing neuronal death, and maintaining mitochondrial structure and function following intracerebral hemorrhage .

What applications are MIC19 antibodies suitable for?

Current commercially available MIC19 antibodies have been validated for multiple research applications. Rabbit polyclonal antibodies against MIC19 are suitable for Western blotting (WB), immunohistochemistry on paraffin-embedded samples (IHC-P), immunocytochemistry/immunofluorescence (ICC/IF), and immunoprecipitation (IP) . These antibodies have been cited in multiple publications, demonstrating their reliability for research purposes . When performing immunoprecipitation, researchers should use approximately 6 μg of antibody per reaction with 0.5-1 mg of whole cell lysate to effectively capture MIC19 protein complexes . For Western blotting applications, brief exposure times (around 30 seconds) are typically sufficient for detection of MIC19 with chemiluminescence methods .

How can researchers validate the specificity of MIC19 antibodies?

Validating antibody specificity for MIC19 should follow a multi-step approach. First, researchers should perform Western blot analysis across multiple cell lines from different species to confirm the predicted band size of 26 kDa . Second, knockdown or knockout of MIC19 expression using siRNA or CRISPR-Cas9 techniques should be employed to verify the disappearance or reduction of the detected signal . Immunoprecipitation followed by mass spectrometry can further confirm antibody specificity by identifying known MIC19 interaction partners such as other MICOS complex components (MIC60, MIC25, MIC27, MIC26) . Additionally, immunofluorescence colocalization with established mitochondrial markers (such as TOMM20) should demonstrate the expected mitochondrial localization pattern . Control experiments using IgG from the same species as the MIC19 antibody should be run in parallel to identify any non-specific binding .

What species reactivity is confirmed for commercial MIC19 antibodies?

Commercial MIC19 antibodies have been validated for reactivity with human, mouse, and rat samples . Western blot analyses have specifically confirmed reactivity in human cell lines such as Jurkat (T cell leukemia cells) and in mouse cell lines including TCMK-1 (kidney epithelial cells) and NIH/3T3 (embryo fibroblasts) . While the antibodies may potentially work in other species with high sequence homology to human CHCHD3, researchers should conduct preliminary validation experiments when using the antibodies in non-validated species . The high conservation of MIC19 across mammalian species suggests that many commercial antibodies may cross-react with additional species, but this requires experimental confirmation .

How does the oxidation status of MIC19 regulate MICOS assembly?

The oxidation status of MIC19 plays a critical role in regulating MICOS complex assembly and function. To study this phenomenon, researchers employ indirect thiol trapping techniques to determine the oxidation state of MIC19's cysteine residues . This methodology involves first blocking any free cysteine residues with iodoacetamide (IA, 50 mM), followed by reduction of disulfide bonds using TCEP (Tris-(2-carboxyethyl)phosphine, 10 mM), and subsequently labeling newly freed thiols with AMS (4-acetamido-4′-maleimidylstilbene-2,2′-disulfonic acid, 15 mM) .

A modified approach for detecting Mic19 conjugated to other proteins involves preincubation with DTT (50 mM) before solubilization . The oxidation status affects protein-protein interactions within the MICOS complex, particularly between MIC19 and other subunits such as MIC60. When studying oxidation-dependent interactions, researchers should maintain reducing or non-reducing conditions consistently throughout sample preparation to avoid artificial oxidation of cysteine residues . Changes in migration pattern on SDS-PAGE under different redox conditions can provide insights into the structural changes of MIC19 that regulate its assembly into the MICOS complex.

What methodologies are optimal for studying MIC19's role in neuroprotection?

To investigate MIC19's neuroprotective functions, researchers should employ a multi-faceted approach combining in vivo and in vitro models. In vivo, intracerebral hemorrhage (ICH) models in rats have proven effective, with evaluation of MIC19 protein levels at 24 hours post-ICH induction using Western blot analysis . Viral vectors can be used to either overexpress or knockdown MIC19 expression, followed by assessment of neurological outcomes using standardized behavioral tests .

For in vitro studies, primary cortical neurons treated with oxygen hemoglobin (OxyHb) to mimic hemorrhagic conditions show increased MIC19 expression at 6 hours post-treatment . Cell viability can be assessed using live-dead cell staining, while mitochondrial function can be evaluated through:

• JC-1 staining to measure mitochondrial membrane potential

• MitoSOX staining to quantify mitochondrial oxidative stress

• Electron microscopy to examine mitochondrial ultrastructure

The interaction between MIC19 and SAM50 appears critical for neuroprotection and can be studied using co-immunoprecipitation (Co-IP) techniques. The disruption of this interaction after ICH and its restoration through overexpression of both proteins offers a mechanical insight into MIC19's protective effects .

What techniques can researchers use to study the protein-protein interactions of MIC19?

Studying MIC19's interactions with other proteins requires robust interaction proteomics approaches. One effective strategy involves expressing C-terminally tagged (HA-FLAG epitope) MIC19 in cell lines via lentiviral vectors, followed by immunoprecipitation and mass spectrometry (IP-MS) . This approach has successfully identified MIC19's interactions with other MICOS components and mitochondrial proteins.

For validation of specific interactions, researchers should employ:

• Reciprocal immunoprecipitation using antibodies against both MIC19 and its putative interaction partners

• Proximity ligation assays to visualize interactions in situ

• FRET (Förster Resonance Energy Transfer) or BiFC (Bimolecular Fluorescence Complementation) for live-cell analysis of protein interactions

When preparing samples for immunoprecipitation, gentle lysis conditions using 1% digitonin in Tris-HCl buffer (pH 7.5) with 150 mM NaCl and protease inhibitors preserves native protein complexes . Approximately 0.5 mg of mitochondrial lysate is optimal for endogenous immunoprecipitation using 1 μg of specific antibody. Protein A resin (10 μl) can be used to capture antibody-protein complexes . When running Western blots to detect co-immunoprecipitated proteins with similar molecular weights (e.g., QIL1 and MIC10), separate gels should be used for accurate identification .

How can researchers distinguish between MIC19's mitochondrial and transcriptional roles?

Distinguishing between MIC19's dual roles in mitochondrial structure maintenance and transcriptional regulation requires subcellular fractionation and functional assays. For subcellular localization, researchers should perform careful fractionation to separate mitochondria from nuclear components, followed by Western blot analysis to determine MIC19 distribution . Immunofluorescence microscopy with co-staining for mitochondrial markers (like TOMM20) and nuclear markers can visualize the distribution of MIC19 between these compartments .

To specifically study the transcriptional role, chromatin immunoprecipitation (ChIP) assays can identify MIC19 binding to promoter regions such as the BAG1 promoter . Reporter gene assays using the BAG1 promoter linked to luciferase can quantify the transcriptional repression activity of MIC19. Site-directed mutagenesis of MIC19's nuclear localization signals or mitochondrial targeting sequences can generate mutants that preferentially localize to one compartment, enabling separation of the two functions.

For mitochondrial function analysis, researchers should examine:

• Cristae morphology using electron microscopy

• Mitochondrial membrane potential with fluorescent dyes like JC-1

• Respiratory chain complex activity through oxygen consumption measurements

• MIC19's interactions with other MICOS components through co-immunoprecipitation

What are the optimal import methods for studying MIC19 integration into mitochondria?

Studying MIC19's import into mitochondria requires in vitro import assays with radiolabeled precursor proteins. The methodology involves several critical steps. First, researchers should isolate intact mitochondria using differential centrifugation in isolation buffer (typically 250 mM sucrose, 10 mM MOPS-KOH, pH 7.2) . The import reaction should be performed at 37°C in import buffer supplemented with 3% fatty acid-free bovine serum albumin .

To distinguish between membrane potential-dependent and independent import pathways, researchers can selectively dissipate the electrochemical inner membrane potential using a combination of 8 μM antimycin A, 1 μM valinomycin, and 20 μM oligomycin (VOA) . After adding the radiolabeled MIC19 precursor to the reaction mixture, the import can be stopped by adding 50 mM iodoacetamide or VOA and placing samples on ice.

Non-imported precursor proteins should be removed by treating mitochondria with proteinase K (50 μg/ml) for 15 minutes, followed by inactivation with 2 mM PMSF . Samples should then be washed with SM buffer and analyzed under reducing conditions on SDS-polyacrylamide gels followed by autoradiography. The efficiency of protein import can be quantified through densitometry of autoradiography images using software such as ImageQuantTL .

What controls should be included when using MIC19 antibodies in experimental designs?

When designing experiments with MIC19 antibodies, researchers must include appropriate controls to ensure valid interpretation of results. For Western blotting, positive controls should include cell lines known to express MIC19 such as Jurkat, TCMK-1, or NIH/3T3 . Negative controls should include either MIC19 knockdown cells or tissues where primary antibody is omitted.

For immunoprecipitation experiments, control IgG from the same species as the MIC19 antibody should be used in parallel reactions to identify non-specific binding . When performing immunofluorescence, include controls for antibody specificity such as:

• Secondary antibody-only controls to evaluate background fluorescence

• Pre-absorption controls where the antibody is pre-incubated with excess purified antigen

• Positive controls with known mitochondrial markers for colocalization analysis

In functional studies investigating MIC19 overexpression or knockdown, appropriate vector controls (LV-NC for overexpression, LV-shRNA-NC for knockdown) must be included to account for vector-related effects . When using viral vectors for gene delivery, transduction efficiency should be verified through reporter gene expression or Western blot analysis prior to functional experiments .

What sample preparation methods optimize MIC19 detection in different applications?

Optimal sample preparation for MIC19 detection varies by application. For Western blotting, whole cell lysates prepared in RIPA buffer or mitochondrial fractions isolated through differential centrifugation provide reliable results . Samples should be separated on SDS-PAGE gels and transferred to PVDF or nitrocellulose membranes for immunodetection. Expected molecular weight for MIC19 is approximately 26 kDa .

For immunohistochemistry on paraffin-embedded tissues (IHC-P), proper fixation with 4% paraformaldehyde followed by antigen retrieval (typically heat-induced in citrate buffer, pH 6.0) is essential for optimal staining . For immunofluorescence studies, fixation with 4% paraformaldehyde for 15 minutes at room temperature preserves mitochondrial morphology while maintaining antibody accessibility to MIC19 .

When studying MIC19's oxidation status, special care must be taken during sample preparation. Samples should be processed in the presence of alkylating agents like iodoacetamide (50 mM) to prevent artificial oxidation of cysteine residues . For detecting MIC19-protein conjugates, pretreatment with reducing agents like DTT (50 mM) before solubilization may be necessary .

For immunoprecipitation, gentler lysis conditions using 1% digitonin in Tris-HCl buffer preserve native protein complexes better than harsher detergents like SDS or Triton X-100 . Approximately 0.5 mg of mitochondrial lysate is optimal for endogenous immunoprecipitation experiments targeting MIC19 and its interaction partners .

How can MIC19 antibodies be used to investigate neurodegenerative diseases?

MIC19 antibodies can be powerful tools for investigating neurodegenerative diseases due to the protein's critical role in maintaining mitochondrial structure and function. In intracerebral hemorrhage models, MIC19 expression increases significantly at 24 hours post-injury, suggesting a compensatory neuroprotective response . Researchers can utilize MIC19 antibodies for several applications:

• Immunohistochemistry and immunofluorescence to evaluate MIC19 expression patterns in brain tissue from neurodegenerative disease models or patient samples

• Western blotting to quantify MIC19 protein levels and assess correlation with disease progression

• Co-immunoprecipitation to examine whether MIC19's interactions with other proteins (particularly SAM50) are disrupted in disease states

When studying neurodegenerative conditions, it's valuable to perform triple immunofluorescent staining with MIC19, neuronal markers (such as NeuN), and nuclear stains (like DAPI) to assess the cellular distribution of MIC19 in neurons . Changes in MIC19 localization from the mitochondria to the cytoplasm may indicate mitochondrial dysfunction in disease states. The neuroprotective effects of MIC19 make it a potential therapeutic target, and antibodies can help validate the efficacy of interventions aimed at modulating MIC19 expression or function in neuronal cells .

What insights can MIC19 antibodies provide about mitochondrial dynamics?

MIC19 antibodies are valuable tools for investigating mitochondrial dynamics, particularly regarding cristae structure and the formation of contact sites between inner and outer mitochondrial membranes. Through immunofluorescence microscopy combined with super-resolution techniques, researchers can visualize MIC19 localization at crista junctions . Co-staining with other MICOS components helps understand how the complex assembles and maintains cristae architecture.

In studies of mitochondrial dynamics, MIC19 antibodies can be used to:

• Track changes in MICOS complex composition during mitochondrial fission and fusion events

• Investigate the role of MIC19 in tethering the inner membrane to the outer membrane through its interaction with SAM50

• Examine how stress conditions affect MIC19 distribution and MICOS complex integrity

The interaction between MIC19 and the outer membrane protein SAM50 is particularly interesting for understanding how contact sites are formed between mitochondrial membranes. Co-immunoprecipitation with MIC19 antibodies followed by detection of SAM50 can reveal how this interaction is regulated under different physiological and pathological conditions . When combined with electron microscopy to visualize cristae ultrastructure, these biochemical approaches provide comprehensive insights into mitochondrial membrane dynamics and organization.

How does the MIC19-SAM50 interaction contribute to mitochondrial function?

The interaction between MIC19 and SAM50 (an outer membrane protein) represents a critical molecular bridge between the mitochondrial inner and outer membranes. Recent research indicates that this interaction is significantly disrupted following intracerebral hemorrhage, potentially contributing to mitochondrial dysfunction in this condition . To study this interaction, co-immunoprecipitation (Co-IP) techniques have proven effective, revealing that overexpression of both MIC19 and SAM50 can compensate for the disrupted interaction and help maintain mitochondrial structure .

This MIC19-SAM50 interaction appears essential for maintaining cristae junctions and mitochondrial morphology. When this interaction is compromised, researchers observe cristae junction collapse and abnormal mitochondrial structure . The assembly of the mitochondrial intermembrane space bridging (MIB) complex, which depends on MIC19, is critical for preserving these structures .

Future research directions should focus on:

• Identifying the specific domains of MIC19 and SAM50 responsible for their interaction

• Developing small molecules that can stabilize this interaction under pathological conditions

• Investigating whether post-translational modifications of either protein regulate their binding affinity

The therapeutic potential of targeting this interaction in conditions characterized by mitochondrial dysfunction merits further investigation, with MIC19 antibodies serving as valuable tools for validating such approaches.

What role does MIC19 play in mitochondrial oxidative stress response?

MIC19's involvement in mitochondrial oxidative stress response represents an emerging area of research. Studies using MitoSOX staining have demonstrated that MIC19 overexpression reduces mitochondrial oxidative stress induced by pathological conditions such as intracerebral hemorrhage . Conversely, MIC19 knockdown exacerbates oxidative stress within mitochondria, suggesting that this protein plays a protective role against reactive oxygen species (ROS) damage .

The mechanisms through which MIC19 mitigates oxidative stress remain to be fully elucidated. Potential pathways include:

• Preservation of cristae structure, which is essential for optimal electron transport chain function and minimization of electron leakage

• Maintenance of mitochondrial membrane potential, as demonstrated by JC-1 staining experiments showing that MIC19 overexpression helps preserve membrane potential under stress conditions

• Potential interaction with antioxidant systems or regulation of mitochondrial quality control mechanisms

Researchers investigating MIC19's role in oxidative stress should combine redox-sensitive probes with MIC19 antibody staining to correlate protein localization with ROS production sites. Genetic manipulation of MIC19 expression, coupled with assessment of key oxidative stress markers (protein carbonylation, lipid peroxidation, mtDNA damage), can further illuminate how this protein influences mitochondrial redox homeostasis. This research direction has significant implications for developing mitochondria-targeted antioxidant strategies in various pathologies.